Q: Are you a GHK-Cu factory or a trader

Conclusion: Tolerance of simvastatin 20mg/day during lead-in and the study drug (40mg/day or placebo) in a cohort of patients with cirrhosis with CSPH has been excellent with no evidence of direct drug-induced hepatotoxicity, few confirmed cases of statin-induced muscle injury, no cases of rhabdomyolysis, and no deaths related to study medication Disclosures: David Kaplan: AstraZeneca Inc: Grant/Research Support, Roche Genentech: Independent Contractor, Exact Sciences: Grant/Research Support, Glycotest: Grant/Research Support, Sirtex: Advisor, Exelixis: Advisor, AstraZeneca: Advisor, Rajni Mehta: Nothing to Disclose, Alexander Burdzy: Nothing to Disclose, Sofia Lizza: Nothing to Disclose, Gyorgy Baffy: Nothing to Disclose, Ruben Hernaez: Nothing to Disclose, Alexander Monto: Nothing to Disclose, George Ioannou: Nothing to Disclose, Kristel Hunt: Nothing to Disclose, Tae Hoon Lee: Merck & Co., Inc.: Chapter Authorship of Merck Manual, Salix Pharmaceuticals, Inc

Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys
Occupational exposure to extremely low-frequency magnetic fields and brain tumor risks in the INTEROCC study
Jacksonville residents looking to shed pounds and improve their health may have heard about the HCG diet, but what about the B12 component